ag 1879 has been researched along with Ovarian Neoplasms in 6 studies
3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine: Fyn kinase inhibitor
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ovarian cancer is the leading cause of death from gynecologic malignancies in the United States." | 1.32 | Inhibitors that target protein kinases for the treatment of ovarian carcinoma. ( Arbel, R; Ben-Bassat, H; Hartzstark, Z; Klein, BY; Laufer, N; Levitzki, R; Rojansky, N, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, A | 1 |
| Ahmad, I | 1 |
| Chhikara, BS | 1 |
| Tiwari, R | 1 |
| Mandal, D | 1 |
| Parang, K | 1 |
| Huang, RY | 1 |
| Wang, SM | 1 |
| Hsieh, CY | 1 |
| Wu, JC | 1 |
| Jeong, KJ | 1 |
| Park, SY | 1 |
| Seo, JH | 1 |
| Lee, KB | 1 |
| Choi, WS | 1 |
| Han, JW | 1 |
| Kang, JK | 1 |
| Park, CG | 1 |
| Kim, YK | 1 |
| Lee, HY | 1 |
| Arbel, R | 1 |
| Rojansky, N | 1 |
| Klein, BY | 1 |
| Levitzki, R | 1 |
| Hartzstark, Z | 1 |
| Laufer, N | 1 |
| Ben-Bassat, H | 1 |
| Wakahara, K | 1 |
| Kobayashi, H | 1 |
| Yagyu, T | 1 |
| Matsuzaki, H | 1 |
| Kondo, T | 1 |
| Kurita, N | 1 |
| Sekino, H | 1 |
| Inagaki, K | 1 |
| Suzuki, M | 1 |
| Kanayama, N | 1 |
| Terao, T | 1 |
| Chen, T | 1 |
| Pengetnze, Y | 1 |
| Taylor, CC | 1 |
6 other studies available for ag 1879 and Ovarian Neoplasms
| Article | Year |
|---|---|
Synthesis of 3-phenylpyrazolopyrimidine-1,2,3-triazole conjugates and evaluation of their Src kinase inhibitory and anticancer activities.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Fe | 2011 |
Lysophosphatidic acid induces ovarian cancer cell dispersal by activating Fyn kinase associated with p120-catenin.
Topics: Adherens Junctions; alpha Catenin; Catenins; Cell Adhesion Molecules; Cell Line, Tumor; Delta Cateni | 2008 |
Lysophosphatidic acid receptor 2 and Gi/Src pathway mediate cell motility through cyclooxygenase 2 expression in CAOV-3 ovarian cancer cells.
Topics: Butadienes; Cell Line, Tumor; Cell Movement; CSK Tyrosine-Protein Kinase; Cyclooxygenase 2; ErbB Rec | 2008 |
Inhibitors that target protein kinases for the treatment of ovarian carcinoma.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma; Catechols; Cell Cycle; Cell Division; Dose-Response Rel | 2003 |
Transforming growth factor-beta1-dependent activation of Smad2/3 and up-regulation of PAI-1 expression is negatively regulated by Src in SKOV-3 human ovarian cancer cells.
Topics: DNA-Binding Proteins; Female; Flavonoids; Humans; Intracellular Signaling Peptides and Proteins; MAP | 2004 |
Src inhibition enhances paclitaxel cytotoxicity in ovarian cancer cells by caspase-9-independent activation of caspase-3.
Topics: Animals; Antineoplastic Agents, Phytogenic; Caspase 3; Caspase 9; Caspases; Cisplatin; Cytochromes c | 2005 |